Cargando…
Radioiodine therapy in patients with Graves’ disease and the effects of prior carbimazole therapy
The use of radioiodine as the first line of treatment in Graves’ disease is restricted in India because of its limited availability and an unrealistic risk perception associated with it. Additionally, the effectiveness of radioiodine ablation in Graves’ disease is influenced by many factors. Prior m...
Autores principales: | Karyampudi, Arun, Hamide, Abdoul, Halanaik, Dhanapathi, Sahoo, Jaya Prakash, Kamalanathan, Sadishkumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171893/ https://www.ncbi.nlm.nih.gov/pubmed/25285287 http://dx.doi.org/10.4103/2230-8210.139234 |
Ejemplares similares
-
Differential response of idiopathic sporadic tumoral calcinosis to bisphosphonates
por: Balachandran, Karthik, et al.
Publicado: (2014) -
Congenital hypothyroidism – An usual suspect at an unusual age: A case series
por: Sukumar, Suja P., et al.
Publicado: (2013) -
Long-term carbimazole pretreatment reduces the efficacy of radioiodine therapy
por: Shivaprasad, C., et al.
Publicado: (2015) -
Symptomatic primary hyperparathyroidism in Indians
por: Kamalanathan, Sadishkumar C., et al.
Publicado: (2011) -
Carbimazole-induced cholestatic hepatitis in Graves’ disease
por: Kota, Sunil K., et al.
Publicado: (2013)